BioCentury
ARTICLE | Clinical News

Acarizax regulatory update

April 20, 2017 9:48 PM UTC

ALK-Abello’s Acarizax HDM SLIT tablets received expanded approval in 12 European countries to treat HDM-induced allergic rhinitis in patients ages 12-17. The countries are Austria, Czech Republic, Den...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

Alk-abello A/S